Back

Baseline interleukin1beta expression in peripheral blood monocytes predicts the extent of weight loss and nonalcoholic fatty liver improvement in obese subjects with prediabetes or type 2 diabetes

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Obesity ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Paola Giustina Maria Simeone

G. d Annunzio University, Chieti (Italy)

217 More presentations in this session

Presentation thumbnail
The association between napping and the risk of cardiovascular disease and all-cause mortality: a systematic review and dose-response meta-analysis
Doctor Z. Pan (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Prediction of 10-year and lifetime risk of cancer in individual patients with established cardiovascular disease, results from UCC-SMART and CANTOS
Miss C. van 't Klooster (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Geographical profiles of cardiovascular risk and the risk factors in China: data from a nationwide population-based screening project
Assistant Professor C. Wu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Associations between life-course frailty and later-life heart size and function in the 1946 NSHD British birth cohort-an epidemiological study
Mr C. Topriceanu (London, GB)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
Doctor P. Welsh (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Risk Factors and Prevention ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Functional and transcriptional differences in monocytes from children with obesity compared to children of healthy weight
28 August 2021
thumbnail
Congress Presentation
Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers
2 September 2019
thumbnail
Congress Presentation
Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab
1 September 2019
thumbnail
Congress Presentation
Is GLP-1 insufficiency a coronary risk factor? - a multicenter observational study, BOREAS-CAD2
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources